Mirum Pharmaceuticals, Inc.
MIRM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001759425
In the last 90 days, Mirum Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 9 sales; 326 institutions reported holding it in 13F filings for Q2 2026, worth $8.36B in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Mirum Pharmaceuticals, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 272 | 8 | 284 | +20 |
| Shares | 57.3M | 423.0K | 61.0M | +4.11M (+7.2%) |
| Value | $4.20B | $31.0M | $4.82B | +$647.5M (+15.5%) |
8 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (62)
Institutions that held Mirum Pharmaceuticals, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (42)
Institutions that held Mirum Pharmaceuticals, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
Not filed for Q4 2025 yet (8)
Institutions that held Mirum Pharmaceuticals, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| AXA Investment Managers S.A. | 255,688 | $18.7M |
| Cubist Systematic Strategies, LLC | 144,184 | $10.6M |
| Bryce Point Capital, LLC | 6,319 | $463.2K |
| Point72 Hong Kong Ltd | 4,986 | $365.5K |
| CIBC Bancorp USA Inc. | 4,303 | $315.5K |
| Glenmede Investment Management, LP | 3,315 | $243.0K |
| Point72 (DIFC) Ltd | 2,702 | $198.1K |
| Point72 Europe (London) LLP | 1,454 | $106.6K |